Armata Pharmaceuticals Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.7% | +35.7% | -15.8% | +0.0% | +0.0% | +116.3% | +151.2% | -58.4% | -33.1% | -46.7% | +2.3% | -45.4% | -16.4% | -14.3% | -84.5% | +13.7% | -9.9% | +92.7% | +108.9% | +11.8% | +1.4% | +4.0% | +247.3% | -17.5% | +4.9% | -23.7% | +9.0% | +36.3% | +15.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -25.7% | – | – | +15,866.7% | +34.7% | -75.1% | +313.0% | -64.9% | -31.7% | +793.5% | -18.6% | -17.1% | +7.7% | -69.8% | +208.4% | -9.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,676.1% | -9.0% | -22.5% | -7.0% | +14.2% | – | – | – | |
| – | +3,100.0% | -71.9% | +622.2% | -96.9% | -750.0% | – | – | – | – | -532.4% | – | -137.2% | – | +295.8% | -399.5% | – | – | -152.8% | – | – | -168.2% | – | -734.5% | – | – | – | -2,297.3% | – | – | |
| – | +44.4% | +15.4% | -53.3% | -71.4% | +850.0% | +47.2% | +57.7% | -87.2% | -43.9% | +29.1% | +64.0% | -87.9% | +584.0% | +33.2% | -85.1% | -51.8% | +92.5% | +1,078.4% | -82.5% | +32.9% | -79.2% | -24.1% | +197.7% | +529.0% | +58.3% | +69.6% | +268.3% | -76.9% | -71.2% | |
| – | -8.5% | -23.3% | – | -158.5% | – | -143.6% | +224.9% | -65.5% | -87.3% | +29.1% | +50.0% | -94.8% | +1,506.3% | +28.8% | – | – | -103.3% | +1,078.4% | -82.5% | +32.9% | -79.2% | -24.1% | – | -128.6% | +58.3% | +69.6% | +267.9% | -76.9% | -71.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -101.4% | – | +31.3% | -19.9% | +131.2% | +16.8% | +65.3% | -100.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | -100.0% | – | – | -35.4% | -28.3% | |
| – | -3.1% | +18.1% | -103.3% | – | -39.5% | +378.9% | -53.6% | -42.2% | +99.9% | +44.9% | -110.3% | – | +556.5% | -101.1% | – | -61.8% | +2,742.3% | – | – | -43.6% | +20.3% | +43.6% | -27.9% | +158.6% | +9.9% | +72.5% | +22.7% | -35.2% | -26.7% | |
| – | – | – | – | – | – | +1,469.5% | -138.9% | – | – | +54.3% | -253.2% | – | – | -209.7% | – | – | – | -170.7% | – | -231.2% | – | – | -223.3% | – | -84.5% | +614.2% | -134.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.